EO 14195Executive OrderTrump 47 · R

Executive Order 14195

Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China

This executive order imposes an additional 10 percent ad valorem tariff on all goods imported from China, effective February 4, 2025, citing China's failure to stop the flow of fentanyl precursor chemicals and related transnational criminal activity. The order expands a previously declared national emergency and terminates inconsistent prior trade directives with China.

Impact dates

  1. Secretary of Homeland Security to issue Federal Register notice modifying HTSUS

  2. Additional 10% tariff takes effect on PRC goods entered for consumption

  3. Goods loaded or in transit before this time exempt if certified to CBP

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Mechanisms

Tariff

Role pressure

  • AdverseImporterAdditional 10% duty on all PRC goods with no product exclusions; compliance costs and price increases
  • MixedDomestic producerPotential competitive benefit vs. higher input costs if reliant on Chinese components; no sector-specific protection
  • AdverseDownstream manufacturerBroad tariff coverage increases input costs across supply chains with limited near-term alternative sourcing
  • AdverseTrading-partner exporterPRC-based exporters face immediate demand reduction and price compression; retaliation risk
  • UncertainEquipment supplierDe minimis elimination affects e-commerce logistics equipment and small parcel handling systems

Geographies

Exposure dates

  • Additional 10% tariff takes effect on PRC goods entered for consumption

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

AAAlcoaGOOGLAlphabetAAPLAppleAMATApplied MaterialsADMArcher Daniels MidlandASMLASMLAVGOBroadcomBGBungeCATCaterpillarCENXCentury AluminumCLFCleveland-CliffsCTVACortevaDEDeereLLYEli LillyFFordGMGeneral MotorsHYMTFHyundai MotorINTCIntelQQQInvesco QQQ TrustJNJJohnson & JohnsonMRKMerckMETAMeta PlatformsMUMicron TechnologyMSFTMicrosoft

Confidence: high · Policy alerts

Key directives

  • Impose additional 10% ad valorem duty on all PRC products effective February 4, 2025
  • Secretary of Homeland Security to modify HTSUS via Federal Register notice
  • Eliminate de minimis duty-free treatment under 19 U.S.C. 1321 for covered articles
  • Terminate, suspend, or modify inconsistent prior presidential trade directives regarding PRC
  • Require foreign trade zone admission as 'privileged foreign status' for covered articles
  • Prohibit drawback on duties imposed by this order
  • Interagency consultation and reporting on PRC compliance with anti-opioid measures
  • Tariff removal contingent on presidential determination of PRC adequate steps

Who is ordered

Timeline

Immediate

  • 10% additional tariff takes effect February 4, 2025 at 12:01 a.m. ET
  • de minimis duty-free treatment eliminated for Chinese imports
  • drawback eliminated for affected duties
  • foreign trade zone 'privileged foreign status' requirement begins

Near term (90d)

  • Secretary of Homeland Security to issue Federal Register notice modifying HTSUS
  • ongoing interagency consultations on PRC compliance
  • potential tariff expansion if PRC retaliates

Long term

  • Tariffs remain until President determines PRC has taken adequate steps to alleviate opioid crisis
  • possible structural shift in US-China trade flows
  • potential escalation to higher or broader duties

Risks & tensions

  • Retaliation risk: Section 2(c) explicitly contemplates PRC countermeasures and authorizes presidential escalation
  • Legal vulnerability: IEEPA tariff authority for trade policy is contested; prior uses challenged in courts
  • Supply chain disruption: 3-day implementation window (Feb 1 signing to Feb 4 effective date) creates compliance scramble
  • De minimis elimination particularly impacts e-commerce and small parcel importers
  • Conditionality tension: Tariff removal tied to subjective presidential determination of PRC 'adequate steps' with no objective criteria specified
  • Overreach concern: Broad framing of national emergency may strain IEEPA's intended scope
  • Inconsistent prior directives terminated but not enumerated, creating legal uncertainty
Executive Order 14195: Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China · Executive Orders